Variation of Liver SUV on 18FDG-PET/CT Studies in Women With Breast Cancer
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
PURPOSE: It has been proposed to use liver as reference organ when assessing tumor response with PET. We investigated whether liver FDG uptake is dependent on clinical, biological, or technical factors. METHODS: Sixty-one women with breast carcinoma had FDG-PET/CT imaging at baseline and then after the second course of neoadjuvant chemotherapy. SUV values were measured over the primary breast tumor and in a region of interest of 30-mm diameter within the liver. RESULTS: Liver SUVmean values for the 61 women were not different before and after the 2 courses of chemotherapy (2.27 vs 2.35; P = 0.18). No significant correlation was found between the delay postinjection and liver SUV. Liver SUVmean increased with blood glucose level (P = 0.007 on baseline PET studies, and P = 0.067 on postchemotherapy studies). Liver SUVmean increased significantly with increasing patient age, which was observed on baseline (P = < 0.001) and postchemotherapy studies (P = 0.002). Again, liver SUVmean increased with body weight (P = 0.037 on baseline studies and 0.003 on postchemotherapy studies). On multivariate analysis, 2 independent variables remained correlated to liver SUV, namely, age and weight. We found no statistically significant correlation between the studied physiological variables and breast tumor SUVmax. However, there was a trend for lower SUVmax with increasing blood glucose level or age. CONCLUSIONS: FDG liver uptake depends on many factors such as age, weight, and blood glucose level. Some of these variables seem to have an opposite impact on tumor SUVmax. These findings challenge the usefulness of liver as reference.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
The citation lists are queued
They are fetched later and appear here then.
References 17 · Cited by 35
Research works printed but not linked: 1
- Groheux, 2010, Assessment of response after two cycles of neoadjuvant chemotherapy in locally advanced breast cancer using FDG PETCT., Eur J Nucl Med Mol Imaging, 37, S236
Metadata
- Authors
- Groheux, D., Delord, M., Rubello, D., Colletti, P. M., Nguyen, M.-L., & Hindié, E.
- Affiliations
- Hôpital Saint-Louis (FR)
- Institut Universitaire d'Hématologie (FR)
- Ospedale Santa Maria della Misericordia di Rovigo (IT)
- University of Southern California (US)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Corresponding author
- Groheux, David
- Nguyen, Minh-Loan
- Venue
- Clinical Nuclear Medicine
- Published
- 2013-06
- Volume
- 38
- Issue
- 6
- Pages
- 422-425
- ISSN
- 0363-9762 (ISSN-L)
- OpenAlex
- W2089284140
- Cited by
- 35
- References
- 17
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 4 · 2013: 2
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Nuclear Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- liver SUV, FDG uptake, breast cancer, neoadjuvant chemotherapy, tumor response assessment, blood glucose, patient age, body weight, SUVmax, PET/CT
- MeSH terms
- Adult, Age Factors, Aged, Blood Glucose, Body Weight, Breast Neoplasms, Female, Humans, Liver, Middle Aged, Radiography, Radionuclide Imaging, Multivariate Analysis, Fluorodeoxyglucose F18, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Variation of Liver SUV on 18FDG-PET/CT Studies in Women With Breast Cancer. https://app.cochat.ai/papers/10.1097/rlu.0b013e3182872f0e
- The paper
- Groheux, D., Delord, M., Rubello, D., Colletti, P. M., Nguyen, M.-L., & Hindié, E. (2013). Variation of Liver SUV on 18FDG-PET/CT Studies in Women With Breast Cancer. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0b013e3182872f0e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.